In 2015, Johns Hopkins scientists proved that scleroderma is often a casualty of war: it is the unfortunate consequence of the body’s battle to fight off cancer. We have since […]
LEAP Rounds – Fall 2022
Promotions
LEAP Rounds – Holiday 2021
The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
LEAP Rounds – Fall 2021
A prevalent belief among rheumatologists has been that an accurate diagnosis of Sjögren’s is not essential because of the lack of disease-modifying therapies. But a correct diagnosis is very important […]
LEAP Rounds – Spring 2020
Corticosteroids (prednisone) are the mainstay of therapy for systemic lupus erythematosus (SLE). Prednisone works: it has anti-inflammatory and immunosuppressive actions in SLE. This is why doctors who treat lupus patients […]
LEAP Rounds – Fall 2019
The first thing to remember is that everybody with a diagnosis of scleroderma is at risk of developing lung disease — either interstitial lung disease (ILD), which affects about 60 […]
Maintenance therapy in well-controlled vasculitis: Is it ever ok to stop?
“Whether or not” and “how” to taper off the last bit of medication for patients with clinically stable ANCA-associated vasculitis are hotly debated topics in the vasculitis field.
